Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05884307 · ClinicalTrials.gov registry record · NA
Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
A NA study of Gender Dysphoria, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 138
- Enrollment target
- 1
- Study location
NCT05884307: Completed NA study of Gender Dysphoria, sponsored by University of Wisconsin, Madison.
NCT05884307 is a NA study of Gender Dysphoria that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 138 participants, below the 161-participant average among 8 other Gender Dysphoria trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05884307, a NA study of Gender Dysphoria, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
- 1
- Study location
Study Summary
The current project aims to improve the well-being of trans and nonbinary (TNB) individuals through an online intervention (Trans Care) targeting the reduction of symptoms of gender dysphoria. The Trans Care intervention will involve the creation of an online intervention comprised of eight modules intended to reduce symptoms of gender dysphoria, increase active coping, and improve the well-being of TNB individuals. Aim 1 is a feasibility and acceptability study of the proposed intervention and will enroll 100 TNB participants to provide feedback to inform a follow-up randomized controlled trial.
Primary Outcome
The AIM is a 4-item measure of intervention acceptability, each item is rated on a 1-5 scale, with 1 = not at all acceptable and 5 = very acceptable. Total mean scores range from 1 - 5, higher scores indicate higher acceptability.
Conditions Studied
Interventions
- OTHER Trans Care Web App
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2024-05-23 |
| Est. Completion | 2024-08-28 |
| Phase | NA |
What the finished NCT05884307 record still lists
NCT05884307 is an interventional study that assigns participants to a tested intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap, below the 161-participant average among 8 other Gender Dysphoria trials with a reported enrollment target (14% lower).
The record links to 1 condition, with Gender Dysphoria appearing as the primary indexed condition, and to 1 intervention - of which Trans Care Web App is the first listed.
NCT05884307 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05884307 about?
NCT05884307 is a clinical study titled "Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria". The current project aims to improve the well-being of trans and nonbinary (TNB) individuals through an online intervention (Trans Care) targeting the reduction of symptoms of gender dysphoria. The Trans Care intervention will involve the creation of an online intervention comprised of eight modules ...
What is the current status of trial NCT05884307?
This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2024-05-23. Estimated completion is 2024-08-28.
What conditions does trial NCT05884307 study?
This clinical trial studies the following conditions: Gender Dysphoria.
What interventions are being tested in trial NCT05884307?
The interventions under investigation include: Trans Care Web App (OTHER).
Who is sponsoring clinical trial NCT05884307?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05884307 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gender Dysphoria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05884307's enrollment target sits among peer trials
138 4th of 8 higher than 5 of 8 other Gender Dysphoria trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gender Dysphoria trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy
RECRUITING · NA
-
Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth
RECRUITING
-
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
RECRUITING · Phase 3
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
RECRUITING · Phase 3
-
Effect of Nitropaste in Chest Masculinizing Surgery
RECRUITING · Phase 4
-
Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI